HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells

Immunobiology

Volumn 215, Issue 12, 2010, Pages 956-962

  Luan, Zheng Gang ^a   Zhang, Hao ^a   Yang, Ping Ting ^a   Ma, Xiao Chun ^a   Zhang, Cheng ^a   Guo, Ren Xuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Endothelium; Ethyl pyruvate; High mobility group box protein 1; Inflammation; Nuclear factor kappa B; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR MONOCLONAL ANTIBODY; ETHYLPYRUVATE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; PYRUVIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

ANTIBODIES; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; PROTEIN TRANSPORT; PYRUVATES; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 78049291345     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.11.001     Document Type: Article

References (37)

1. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
2. Bianchi M.E., Manfredi A. Chromatin and cell death. Biochim. Biophys. Acta. 2004, 1677:181-186.
3. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., Shaw A., Migheli A., Stern D. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 1993, 143:1699-1712.
4. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell Biol. 1999, 19:5237-5246.
5. Czura C.J., Wang H., Tracey K.J. Dual roles for HMGB1: DNA binding and cytokine. J. Endotoxin Res. 2001, 7:315-321.
6. Degryse B., Bonaldi T., Scaffidi P., Müller S., Resnati M., Sanvito F., Arrigoni G., Bianchi ME. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 2001, 152:1197-1206.
7. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
8. Fink M.P. Ethyl pyruvate: a novel treatment for sepsis. Curr. Drug. Targets 2007, 8:515-518.
9. Fink M.P. Ethyl pyruvate: a novel anti-inflammatory agent. J. Intern. Med. 2007, 261:349-362.
10. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
11. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
12. Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J. Intern. Med. 2004, 255:351-366.
13. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275:40096-40105.
14. Harja E., Bu D.X., Hudson B.I., Chang J.S., Shen X., Hallam K., Kalea A.Z., Lu Y., Rosario R.H., Oruganti S., Nikolla Z., Belov D., Lalla E., Ramasamy R., Yan S.F., Schmidt A.M. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J. Clin. Invest. 2008, 118:183-194.
15. Ito I., Fukazawa J., Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 2007, 282:16336-16344.
16. Jaffe E.A., Nachman R.L., Bedker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 1973, 52:2745-2756.
17. Kalinina N., Agrotis A., Antropova Y., DiVitto G., Kanellakis P., Kostolias G., Ilyinskaya O., Tararak E., Bobik A. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2320-2325.
18. Kawahara K., Setoyama K., Kikuchi K., Biswas K.K., Kamimura R., Iwata M., Ito T., Morimoto Y., Hashiguchi T., Takao S., Maruyama I. HMGB1 release in co-cultures of porcine endothelial and human T cells. Xenotransplantation 2007, 14:636-641.
19. Li W., Sama A.E., Wang H. Role of HMGB1 in cardiovascular diseases. Curr. Opin. Pharmacol. 2006, 6:130-135.
20. Lehr H.A., Bittinger F., Kirkpatrick C.J. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?. J. Pathol. 2000, 190:373-386.
21. Li N., Karin M. Is NF-kappa B the sensor of oxidative stress. FASEB J. 1999, 13:1137-1143.
22. Mozaffarian N., Casadevall A., Berman J.W. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans. J. Immunol. 2000, 165:1541-1547.
23. Rouhiainen A., Imai S., Rauvala H., Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 2000, 84:1087-1094.
24. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164:441-449.
25. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., Lepäntalo M., Carpén O., Parkkinen J., Rauvala H. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004, 104:1174-1182.
26. Riedemann N.C., Guo R.F., Ward P.A. Novel strategies for the treatment of sepsis. Nat. Med. 2003, 9:517-524.
27. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498:99-111.
28. Sappington P.L., Han X., Yang R., Delude R.L., Fink M,P. Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers. J. Pharmacol. Exp. Ther. 2003, 304:464-476.
29. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
30. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., Tanji N., Lu Y., Lalla E., Fu C., Hofmann M.A., Kislinger T., Ingram M., Lu A., Tanaka H., Hori O., Ogawa S., Stern D.M., Schmidt A.M. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
31. Treutiger C.J., Mullins G.E., Johansson A.S., Rouhiainen A., Rauvala HM., Erlandsson-Harris H., Andersson U., Yang H., Tracey K.J., Andersson J., Palmblad J.E. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 2003, 254:375-385.
32. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 2000, 275:25781-25790.
33. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 2005, 4:673-684.
34. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
35. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., Tracey K.J. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-392.
36. Yang H., Ochani M., Li J., Qiang.X., Tanovic M., Harris HE., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Wang H., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., Tracey K.J. Reversing established sepsis with antagonists of endogenous HMGB1. Proc. Natl. Acad. Sci. USA 2004, 101:296-301.
37. Yang H., Wang H., Tracey K.J. HMG-1 rediscovered as a cytokine. Shock 2001, 15:247.